DarioHealth (NASDAQ:DRIO) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

DarioHealth Corp. (NASDAQ:DRIO) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.95 and traded as low as $0.89. DarioHealth shares last traded at $0.90, with a volume of 1,007,761 shares trading hands.

DarioHealth Stock Down 41.2 %

The stock has a 50-day moving average of $0.81 and a 200 day moving average of $0.95. The company has a market cap of $30.69 million, a P/E ratio of -0.96 and a beta of 1.39. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

Institutional Trading of DarioHealth

Several large investors have recently bought and sold shares of DRIO. Appian Way Asset Management LP lifted its holdings in shares of DarioHealth by 2.5% in the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after acquiring an additional 34,990 shares during the last quarter. DLK Investment Management LLC boosted its position in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock valued at $113,000 after buying an additional 41,943 shares in the last quarter. Finally, XTX Topco Ltd increased its holdings in shares of DarioHealth by 81.4% during the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after buying an additional 13,219 shares in the last quarter. 33.39% of the stock is owned by institutional investors and hedge funds.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.